Disclosures for "Associations Between Serum Biomarkers, Social Factors, and ASCVD Scores in African American Men: Interim Analysis from an Ongoing Clinical Trial"
-
Dr. Shafiq has nothing to disclose.
-
Rajeet Shrestha has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME program with Clinical Care Options .
-
Dr. Still has nothing to disclose.
-
Prof. Burant has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AMOS Corporation. The institution of Prof. Burant has received research support from NIH. The institution of Prof. Burant has received research support from VA.
-
Ms. Surdam has nothing to disclose.
-
Author has nothing to disclose
-
Ms. Fiorelli has nothing to disclose.
-
Mrs. Krehel-Montgomery has nothing to disclose.
-
Ms. Lute has nothing to disclose.
-
Dr. Sundararajan has stock in Boston Scientific Corp. Dr. Sundararajan has stock in Cisco Systems. Dr. Sundararajan has stock in Coca Cola Co. Dr. Sundararajan has stock in Cummins Inc. Dr. Sundararajan has stock in Hartford Insurance group. Dr. Sundararajan has stock in Johnson and Johnson. Dr. Sundararajan has stock in Merck and Company Inc. Dr. Sundararajan has stock in Microsoft. Dr. Sundararajan has stock in Netflix. Dr. Sundararajan has stock in Novartis. Dr. Sundararajan has stock in Oracle Corp. Dr. Sundararajan has stock in Pepsico. Dr. Sundararajan has stock in Proctor and Gamble. Dr. Sundararajan has stock in Qualcomm Inc. Dr. Sundararajan has stock in Travelers Cos Inc. Dr. Sundararajan has stock in Vertex Pharmacueticals. Dr. Sundararajan has stock in Visa Inc. Dr. Sundararajan has stock in Wallmart. Dr. Sundararajan has stock in Zoetis Inc Cl A. The institution of Dr. Sundararajan has received research support from NIH. The institution of Dr. Sundararajan has received research support from AHA.
-
Dr. SAJATOVIC has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck, Janssen, Teva, Otsuka, Alkermes. The institution of Dr. SAJATOVIC has received research support from Neurelis, Intra-Cellular, Merck, Otsuka, Alkermes, International Society for Bipolar Disorders (ISBD), National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), . Dr. SAJATOVIC has received publishing royalties from a publication relating to health care.